Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: certificate (68), licence (138), tag (10)

Nivolumab

Description: Chemotherapy Protocol GASTRIC CANCER Nivolumab Regimen • Gastric Cancer – Nivolumab Indication • The treatment of advanced gastric or ga
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Upper-gastro-intestinal/Nivolumab.pdf

Long-term continuous positive airway pressure (CPAP) treatment - patient information

Description: This leaflet explains what obstructive sleep apnoea (OSA) is, what long-term continuous positive airway pressure (CPAP) treatment for OSA involves
Url: /Media/UHS-website-2019/Patientinformation/Respiratory/Long-term-continuous-positive-airway-pressure-CPAP-treatment-3385-PIL.pdf

AmB LEAM (split)-Lomustine-Cytarabine-Etoposide-Melphalan

Description: Chemotherapy Protocol LYMPHOMA LOMUSTINE-CYTARABINE-ETOPOSIDE (split)-MELPHALAN (LEAM) Ambulatory Re
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/AmB-LEAM-split-Lomustine-Cytarabine-Etoposide-Melphalan.pdf

Avelumab-Axitinib

Description: Chemotherapy Protocol RENAL CELL AVELUMAB-AXITINIB Regimen • Renal Cell - Avelumab-Axitinib Indication • Unresectable local
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Axitinib-Avelumab.pdf

Annual report 20-21

Description: 2020/21 Incorporating the quality report University Hospital Southampton NHS Foundation Trust Annual Report and Accounts 2020/21 Presented to Parliament
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/annual-report-20-21.pdf

Atezolizumab-Bevacizumab

Description: Chemotherapy Protocol Hepatocellular Cancer ATEZOLIZUMAB-BEVACIZUMAB Regimen  HCC-Atezolizumab-Bevacizumab Indication  Atezolizumab in combinati
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Atezolizumab-Bevacizumab.pdf

Visiting guidelines: Burley and Lyndhurst wards - patient information

Description: This factsheet outlines the visiting guidelines on the maternity wards at Princess Anne Hospital.
Url: /Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Visiting-guidelines-Burley-and-Lyndhurst-wards-3137-PIL.pdf

Ipilimumab(1mg/kg)-Nivolumab(3mg/kg)

Description: Chemotherapy Protocol RENAL CANCER IPILIMUMAB (1mg/kg)-NIVOLUMAB(3mg/kg) Regimen • Renal – Ipilimumab (1mg/kg)-Nivolumab (3mg/kg) Indication
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Ipilimumab1mgkg-Nivolumab3mgkg.pdf

Bendamustine-Polatuzumab-Rituximab

Description: Chemotherapy Protocol LYMPHOMA BENDAMUSTINE-POLATUZUMAB-RITUXIMAB Regimen • Lymphoma – Bendamustine-Po
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Bendamustine-Polatuzumab-Rituximab.pdf

Bendamustine-Obinutuzumab

Description: Chemotherapy Protocol Non-Hodgkin Lymphoma Bendamustine-Obinutuzumab Regimen • NHL – Bendamustine-Obin
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Bendamustine-Obinutuzumab.pdf

111 to 120 of 192

Previous … 10 11 12 13 14 … Next